FUJIFILM SonoSite has launched itsnew redesigned version of the SonoSite Institute, a comprehensive online educational resource dedicated to empowering and educating health care providers about point-of-care ultrasound (POCUS). The company said that the enhanced website had taken account of feedback from current users worldwide to offer an improved user experience, easier-to-locate content, and reconfigured learning paths. The SonoSite Institute is available exclusively to FUJIFILM SonoSite customers and is included with all system purchases and accessible by registering with the serial number of the device.
Originally launched in November 2015, the SonoSite Institute is a content-rich, web-based resource available on any internet-enabled device – phone, tablet or PC – allowing users to learn at their own pace to gain confidence in the use of POCUS in their everyday practice while branching out to become proficient in a variety of specialities. The platform includes case studies, webinars, clinical images, videos and more across a wide array of specialities. Redesigned learning paths include courses that allow users to rate their base knowledge and track progress with built-in evaluation benchmarks and, on successful completion, print out certificates. In addition, users will find new speciality-specific content created by POCUS practitioners, including in-depth treatment of topics such as central line management and eFAST exams, as well as trending applications such as perioperative medicine and transoesophagal echocardiography.
For further information about FUJIFILM SonoSite and the SonoSite Institute visit www.sonosite.com/education/sonosite-institute
Latest from Tom Mulligan
- EVENT PREVIEW: CPhI North America opens next week!
- NEW BUSINESS: SK biotek and AMPAC Fine Chemicals have ambitious CDMO plans
- NEW TECHNOLOGY: Polyplus-transfection develops GMP-grade therapeutic virus reagent
- Mogrify raises $3.7 million seed funding to support direct cellular conversion for cell therapy
- Owlstone Medical partners with Shanghai Renji Hospital to pioneer Breath Biopsy lung cancer trial
- Chemspace and LabNetwork collaborate to extend access to chemical databases
- TECHNOLOGY UPDATE: Catalent invests over $27 million to commercialise next-generation ODT Zydis Ultra
- SGS reports successful Phase 2 results for novel influenza vaccine, validating its H3N2 A/Belgium challenge agent
- NEW TECHNOLOGY: Horizon Discovery and Rutgers University develop new gene editing approach: ‘base editing’
- EVENT REVIEW: Busy sessions at BIO-Europe Spring!